Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.
2.

Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP.

Thromb Haemost. 1998 Sep;80(3):382-7.

PMID:
9759614
3.

Contraception for women with diabetes: an update.

Skouby SO, Mølsted-Pedersen L, Petersen KR.

Baillieres Clin Obstet Gynaecol. 1991 Jun;5(2):493-503. Review.

PMID:
1954724
4.
5.

Smoking and use of oral contraceptives: impact on thrombotic diseases.

Lidegaard O.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S357-63.

PMID:
10368521
6.

[Combined contraceptives and cardiovascular risk].

Belaisch J, Hommais-loufrani B.

Contracept Fertil Sex (Paris). 1987 Dec;15(12 Suppl):1-8. French.

PMID:
12315199
7.
8.

Oxidative stress and metabolic syndrome in a Japanese female population.

Kotani K, Yamada T.

Australas J Ageing. 2012 Jun;31(2):124-7. doi: 10.1111/j.1741-6612.2011.00571.x. Epub 2012 Feb 2.

PMID:
22676173
9.
11.

[Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins (author's transl)].

Beaumont V, Lemort N, Lorenzelli L, Mosser A, Beaumont JL.

Pathol Biol (Paris). 1978 Dec;26(9-10):531-7. French.

PMID:
85291
12.

Haemostatic changes and the oral contraceptive pill.

Norris LA, Bonnar J.

Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):545-64. Review.

PMID:
9488791
13.

Idiopathic thromboembolism associated with triphasic oral contraceptives.

Miwa LJ, Edmunds AL, Shaefer MS, Raynor SC.

DICP. 1989 Oct;23(10):773-5.

PMID:
2815853
15.

The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.

Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB.

Clin Pharmacol Ther. 2004 May;75(5):464-75.

PMID:
15116059
16.

Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.

Godsland IF, Crook D, Devenport M, Wynn V.

Contraception. 1995 Sep;52(3):143-9.

PMID:
7587185
17.

The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.

Werawatgoompa S, Vaivanijkul B, Leepipatpaiboon S, Channiyom K, Virutamasen P, Dusitsin N.

Contraception. 1980 Mar;21(3):299-309.

PMID:
7389353
18.

[Cardiovascular risks of oral contraceptives: dose-response relationship].

Kelleher CC.

Contracept Fertil Sex (Paris). 1991 Apr;19(4):285-8. French.

PMID:
12343220
19.

A study of interaction of low-dose combination oral contraceptive with Ampicillin and Metronidazole.

Joshi JV, Joshi UM, Sankholi GM, Krishna U, Mandlekar A, Chowdhury V, Hazari K, Gupta K, Sheth UK, Saxena BN.

Contraception. 1980 Dec;22(6):643-52.

PMID:
7214911
20.

Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.

Cole JA, Norman H, Doherty M, Walker AM.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):339-46. Erratum in: Obstet Gynecol. 2008 Jun;111(6):1449.

PMID:
17267834

Supplemental Content

Support Center